State of Alaska Department of Revenue Increases Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

State of Alaska Department of Revenue increased its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 448.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,737 shares of the health services provider's stock after acquiring an additional 16,955 shares during the period. State of Alaska Department of Revenue owned about 0.06% of Amedisys worth $1,882,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Blue Trust Inc. lifted its stake in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares in the last quarter. HBW Advisory Services LLC purchased a new stake in Amedisys during the 4th quarter worth about $38,000. Versant Capital Management Inc increased its holdings in Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after purchasing an additional 183 shares during the period. KBC Group NV purchased a new stake in Amedisys during the 3rd quarter worth about $63,000. Finally, Signaturefd LLC increased its holdings in Amedisys by 20.9% during the 3rd quarter. Signaturefd LLC now owns 1,367 shares of the health services provider's stock worth $132,000 after purchasing an additional 236 shares during the period. Institutional investors and hedge funds own 94.36% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Stephens restated an "equal weight" rating and set a $101.00 price target on shares of Amedisys in a report on Wednesday. Five investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $100.75.

Amedisys Stock Down 0.2 %

Shares of AMED traded down $0.18 during mid-day trading on Friday, reaching $92.60. The company's stock had a trading volume of 130,693 shares, compared to its average volume of 266,508. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95. The stock has a market cap of $3.03 billion, a PE ratio of 36.75, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The company's 50 day moving average is $90.11 and its 200 day moving average is $93.61.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.